TABLE 2.
Analysis of 10 296 MP patients from 2008 to 2017 in different gender groups. Data were represented as n (%) in total cases and as n (positivity, %) in MP cases
| Group | Total | MP cases | ||
|---|---|---|---|---|
| Male patients | Female patients | Male positive patients | Female positive patients | |
| Total | 5909 (57.4) | 4387 (42.6) | 680 (11.5) | 571 (13.0) |
| 2008 | 77 (53.1) | 68 (46.9) | 15 (19.5) | 18 (26.5) |
| 2009 | 570 (56.4) | 440 (43.6) | 101 (17.7) | 110 (25.0) |
| 2010 | 923 (55.2) | 748 (44.8) | 189 (20.5) | 161 (21.5) |
| 2011 | 782 (61.6) | 487 (38.4) | 47 (6.0) | 23 (4.7) |
| 2012 | 688 (59.4) | 471 (40.6) | 74 (10.8) | 62 (13.2) |
| 2013 | 744 (59.4) | 509 (40.6) | 108 (14.5) | 82 (16.1) |
| 2014 | 710 (59.2) | 489 (40.8) | 57 (8.0) | 37 (7.6) |
| 2015 | 574 (54.3) | 484 (45.7) | 32 (5.6) | 30 (6.2) |
| 2016 | 395 (54.9) | 325 (45.1) | 27 (6.8) | 29 (8.9) |
| 2017 | 446 (54.9) | 366 (45.1) | 30 (6.7) | 19 (5.2) |
| P | .001 | .154 | ||
| χ2 | 27.592 | 13.206 | ||